Artificial intelligence in hepatocellular carcinoma screening: applications and challenges. [PDF]
Rao JX, Li Y, Leng K.
europepmc +1 more source
Efficacy and predictive factors of transarterial chemoembolization combined with lenvatinib plus programmed cell death protein-1 inhibition for unresectable hepatocellular carcinoma. [PDF]
Ma KP, Fu JX, Duan F, Wang MQ.
europepmc +1 more source
Prognostic significance of early alpha fetoprotein and des-gamma carboxy prothrombin responses in unresectable hepatocellular carcinoma patients undergoing triple combination therapy. [PDF]
Zhang T +7 more
europepmc +1 more source
Characterization and Detection Strategy Exploration in Cryptogenic Hepatocellular Carcinoma: Insights From a Super-Aged Region in Japan. [PDF]
Sugihara T +11 more
europepmc +1 more source
Decoding Tumor-Immune Interactions in Hepatocellular Carcinoma Through Network-Centered Identification of CXCR2. [PDF]
Almatroodi SA, Sarwar T, Rahmani AH.
europepmc +1 more source
Des-gamma-carboxy prothrombin and alpha-fetoprotein levels as biomarkers for hepatocellular carcinoma and their correlation with radiological characteristics. [PDF]
Qadeer MA +5 more
europepmc +1 more source
OBJECTIVES: We evaluated two new autoanalyzers, μTAS and Lumipulse for des-γ-carboxyprothrombin (DCP) assay. MATERIAL AND METHODS: Analytical performance was evaluated, and the upper reference limit of the 97.5th percentile for DCP was re-established ...
Hyon-Suk Kim +2 more
exaly +9 more sources
Des-gamma-carboxyprothrombin and hepatoblastoma. [PDF]
The variation of des-gamma-carboxyprothrombin (PIVKA-II, protein induced by vitamin K absence) levels in umbilical cord blood throughout gestation was examined using a highly sensitive method, electrochemiluminescence immunoassay (ECLIA). PIVKA-II levels in infants without any complications were low, but modestly high, exceeding the normal range of ...
J J Lefrere
exaly +10 more sources
Related searches:
Study of the disappearance time of des-gamma-carboxyprothrombin under different conditions
Thrombosis Research, 1989Etude du temps de disparition de ce diagramme-carboxy-prothrombine chez des malades deficients en vitamine K (sans cancer hepatocellulaire) et chez des volontaires normaux apres traitement anticoagulant ...
J J Lefrere, R Girot, J P Soulier
exaly +3 more sources

